What sector does Aarti Pharmalabs Limited belong to?

Aarti Pharmalabs Limited operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.

What is the current share price of AARTIPHARM?

As of the latest available quote, AARTIPHARM traded at ₹826.95. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of AARTIPHARM?

Aarti Pharmalabs Limited has a price-to-earnings (P/E) ratio of about 36.62. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of AARTIPHARM?

The market capitalisation of Aarti Pharmalabs Limited is approximately ₹7,499 Cr.

Is Aarti Pharmalabs Limited profitable?

For its latest reported financial year, Aarti Pharmalabs Limited recorded a net profit margin of about 9.62%.

Does AARTIPHARM pay a dividend?

Aarti Pharmalabs Limited does not currently show a dividend yield in our data.

What is the return on equity (ROE) of AARTIPHARM?

Aarti Pharmalabs Limited has a return on equity (ROE) of about 8.59%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of AARTIPHARM?

Over the past 52 weeks, AARTIPHARM has traded between a low of ₹585.00 and a high of ₹946.10.

Aarti Pharmalabs Limited

AARTIPHARM NSE Healthcare Pharmaceuticals

Microcap 250

₹826.95

+0.15%

Delayed · cached 15 min

Fair value analysis

AARTIPHARM

Aarti Pharmalabs Limited

₹825.75

Close used for this calculation

₹452.35Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

23/100

Profitability6/25

Returns4/25

Balance Sheet9/25

Efficiency4/25

Growth0/25

Weak

Quality radar

Consensus fair value

₹452.35

Above FV

▼ -45.2% against the close used

Model range ₹229.76 – ₹687.94

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹229.76Fair value₹452.35Bull₹687.94

FairClose

52-week traded range

52W low ₹591.9552W high ₹939.50

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Aarti Pharmalabs Limited closed at ₹825.75, 82.5% above the consensus fair value of ₹452.35 drawn from 7 valuation models.

Financial DNA score 23/100 — Weak. P/E of 34.8x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹361.17

-56.3%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

₹353.20

-57.2%

√(22.5 × EPS × BVPS)

EPS=19.27, BVPS=287.72 · outside Graham range (P/E 34.8, P/B 2.9) — asset-light, treat as a rough floor

P/E Fair Value

₹687.94

-16.7%

EPS × 35.7x (sector P/E)

EPS=19.27, Sector P/E=35.7x

EV/EBITDA

₹437.82

-47.0%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=4.73B

Book Value (P/B)

₹229.76

-72.2%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=287.72, ROE=8.6%, g=3%, r=10%

Reverse DCF

₹825.75

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 17.4% | Historical: 0%

Margin of Safety

₹350.58

-57.5%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=467.44, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer